| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |


From the Field of Regeneration Control,*
Institute for
Frontier Medical Science, Kyoto University, Kyoto; the Department of
Nutrition and Physiological Chemistry,
Osaka
University Medical School, Osaka; the Laboratory of Molecular
Genetics,
Institute of Medical Science,
University of Tokyo, Tokyo; and the Department of Aging
Angiology,§
Research Center on Aging and
Adaptation, Shinshu University School of Medicine, Matsumoto, Japan
Apolipoprotein A-II (apoA-II), the second most abundant apolipoprotein of serum high density lipoprotein, deposits as an amyloid fibril (AApoAII) in old mice. Mouse strains with a high incidence of senile amyloidosis have the type C apoA-II gene (Apoa2c), whereas the strains with a low incidence of amyloidosis have the type B apoA-II gene (Apoa2b). In this study, to investigate whether the type B apoA-II protein inhibits the extension of amyloid fibrils, we constructed an adenovirus vector bearing the Apoa2b cDNA (Adex1CATApoa2b), which is expressed under the control of a hepatocyte-specific promoter. The mice were infected with Adex1CATApoa2b before induction of amyloidosis by the injection of AApoAII amyloid fibril seeds. Compared with the mice infected with the control virus, amyloid deposition was suppressed significantly in the mice infected with Adex1CATApoa2b. Fluorometry using thioflavine T also revealed that AApoAII fibril extension was inhibited by the addition of type B apoA-II in vitro. Thus, we propose that Apoa2b contributes as an active inhibitor of amyloid fibril extension and overexpression of amyloid-resistant gene variant may be an attractive therapeutic target in amyloidosis.
This article has been cited by other articles:
![]() |
H. Zhang, J. Sawashita, X. Fu, T. Korenaga, J. Yan, M. Mori, and K. Higuchi Transmissibility of mouse AApoAII amyloid fibrils: inactivation by physical and chemical methods FASEB J, May 1, 2006; 20(7): 1012 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Minami, T. Murakami, K. Horiuchi, M. Miura, T. Noguchi, J.-i. Miyazaki, T. Hamakubo, W. C. Aird, and T. Kodama Interaction between Hex and GATA Transcription Factors in Vascular Endothelial Cells Inhibits flk-1/KDR-mediated Vascular Endothelial Growth Factor Signaling J. Biol. Chem., May 14, 2004; 279(20): 20626 - 20635. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Umezawa, K. Tatematsu, T. Korenaga, X. Fu, T. Matushita, H. Okuyama, M. Hosokawa, T. Takeda, and K. Higuchi Dietary fat modulation of apoA-II metabolism and prevention of senile amyloidosis in the senescence- accelerated mouse J. Lipid Res., April 1, 2003; 44(4): 762 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fu, I. Matsuyama, T. Chiba, Y. Xing, T. Korenaga, Z. Guo, X. Fu, J. Nakayama, M. Mori, and K. Higuchi Extrahepatic Expression of Apolipoprotein A-II in Mouse Tissues: Possible Contribution to Mouse Senile Amyloidosis J. Histochem. Cytochem., June 1, 2001; 49(6): 739 - 748. [Abstract] [Full Text] |
||||
![]() |
J. Wang, T. Matsushita, K. Kogishi, C. Xia, A. Ohta, T. Chiba, A. Nakamura, H. Kondo, M. Mori, M. Hosokawa, et al. Wild Type ApoA-II Gene Does Not Rescue Senescence-Accelerated Mouse (SAMP1) From Short Life Span and Accelerated Mortality J Gerontol A Biol Sci Med Sci, September 1, 2000; 55(9): B432 - B439. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |